Canada markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2113-0.0067 (-3.07%)
At close: 04:00PM EDT
0.2090 -0.00 (-1.09%)
After hours: 07:08PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.29M
Enterprise Value 2.04M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.57
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-85.86%
S&P500 52-Week Change 324.19%
52 Week High 32.9800
52 Week Low 30.1900
50-Day Moving Average 30.3025
200-Day Moving Average 31.2027

Share Statistics

Avg Vol (3 month) 3335.36k
Avg Vol (10 day) 3138.84k
Shares Outstanding 510.63M
Implied Shares Outstanding 611.16M
Float 88.95M
% Held by Insiders 19.53%
% Held by Institutions 13.53%
Shares Short (Apr 15, 2024) 423.08k
Short Ratio (Apr 15, 2024) 40.13
Short % of Float (Apr 15, 2024) 40.24%
Short % of Shares Outstanding (Apr 15, 2024) 40.22%
Shares Short (prior month Mar 15, 2024) 4103.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Nov 29, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-159.83%
Return on Equity (ttm)-1,018.78%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.86M
Net Income Avi to Common (ttm)-18.85M
Diluted EPS (ttm)-10.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)548.72k
Total Cash Per Share (mrq)0.05
Total Debt (mrq)300.81k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.26
Book Value Per Share (mrq)-0.71

Cash Flow Statement

Operating Cash Flow (ttm)-14.14M
Levered Free Cash Flow (ttm)-8M